{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T16:05:34Z","timestamp":1778861134391,"version":"3.51.4"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016238","name":"Alkoholitutkimuss\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016238","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019391","name":"University of Turku Graduate School","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019391","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.schres.2026.01.003","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T01:46:57Z","timestamp":1768182417000},"page":"1-9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Antipsychotic use and associating factors among persons with substance-induced psychosis and first-episode psychotic disorder- A nationwide register-linkage study"],"prefix":"10.1016","volume":"289","author":[{"given":"Jeyaniroshan","family":"Jeyapalan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heidi","family":"Taipale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antti","family":"Tanskanen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jari","family":"Tiihonen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ellenor","family":"Mittendorfer-Rutz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Solja","family":"Niemel\u00e4","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.schres.2026.01.003_bb0005","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1176\/appi.ps.201200156","article-title":"Essential evidence-based components of first-episode psychosis services","volume":"64","author":"Addington","year":"2013","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.schres.2026.01.003_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12888-021-03188-0","article-title":"Scope, quality and inclusivity of international clinical guidelines on mental health and substance abuse in relation to dual diagnosis, social and community outcomes: a systematic review","volume":"21","author":"Alsuhaibani","year":"2021","journal-title":"BMC Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2026.01.003_bb8005","doi-asserted-by":"crossref","DOI":"10.1192\/j.eurpsy.2024.5","article-title":"The effects of antipsychotic discontinuation or maintenance on the process of recovery in remitted first-episode psychosis patients\u2013a systematic review and meta-analysis of randomized controlled trials","volume":"67","author":"B\u00e9chard","year":"2024","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.schres.2026.01.003_bb0020","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1080\/15504263.2011.570118","article-title":"A randomized trial of clozapine vs. other antipsychotics for cannabis use disorder in patients with schizophrenia","volume":"7","author":"Brunette","year":"2011","journal-title":"J. Dual Diagn."},{"key":"10.1016\/j.schres.2026.01.003_bb0025","article-title":"\u201cShort\u201d versus \u201clong\u201d duration of untreated psychosis in people with first-episode psychosis: a systematic review and meta-analysis of baseline status and follow-up outcomes","author":"Catalan","year":"2024","journal-title":"Schizophr. Bull."},{"issue":"5","key":"10.1016\/j.schres.2026.01.003_bb8010","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J. Chronic Dis."},{"key":"10.1016\/j.schres.2026.01.003_bb0030","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1186\/s12888-024-06075-6","article-title":"Real world clinical outcomes of treatment of cannabis-induced psychosis and prevalence of cannabis-related primary psychosis: a retrospective study","volume":"24","author":"Chuenchom","year":"2024","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.schres.2026.01.003_bb0040","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/nrendo.2011.156","article-title":"Metabolic and cardiovascular adverse effects associated with antipsychotic drugs","volume":"8","author":"De Hert","year":"2011","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.schres.2026.01.003_bb0045","doi-asserted-by":"crossref","DOI":"10.1093\/schbul\/sbae034","article-title":"Antipsychotic use and psychiatric hospitalization in first-episode non-affective psychosis and cannabis use disorder: a Swedish nationwide cohort study","volume":"50","author":"Denissoff","year":"2024","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2026.01.003_bb0050","doi-asserted-by":"crossref","DOI":"10.1111\/add.70014","article-title":"Relapse in substance-induced psychosis and associated risk factors. A nationwide register-linkage study from Sweden","author":"Ellil\u00e4","year":"2025","journal-title":"Addiction"},{"key":"10.1016\/j.schres.2026.01.003_bb0055","article-title":"Substance-induced psychoses: an updated literature review","volume":"12","author":"Fiorentini","year":"2021","journal-title":"Front. Psych."},{"key":"10.1016\/j.schres.2026.01.003_bb0060","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2019.00740","article-title":"Antipsychotics for amphetamine psychosis. A systematic review","volume":"10","author":"Fluyau","year":"2019","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.schres.2026.01.003_bb0065","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/wps.20446","article-title":"Improving outcomes of first-episode psychosis: an overview","volume":"16","author":"Fusar-Poli","year":"2017","journal-title":"World Psychiatry"},{"key":"10.1016\/j.schres.2026.01.003_bb0075","article-title":"Antipsychotic treatment patterns in refugees and their Swedish-born peers with first-episode non-affective psychosis: findings from the REMAIN study","volume":"9","author":"Goppers","year":"2023","journal-title":"BJPsych Open"},{"key":"10.1016\/j.schres.2026.01.003_bb0080","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0920-9964(02)00231-1","article-title":"Alcohol and cannabis use in schizophrenia: effects of clozapine vs. risperidone","volume":"60","author":"Green","year":"2003","journal-title":"Schizophr. Res."},{"issue":"4","key":"10.1016\/j.schres.2026.01.003_bb8015","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1080\/08039488.2019.1707283","article-title":"Comparison of psychotropic medication use in the Baltic countries","volume":"74","author":"Harro","year":"2020","journal-title":"Nord. J. Psychiatry"},{"key":"10.1016\/j.schres.2026.01.003_bb0090","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3390\/pharmacy9010060","article-title":"Measuring medicine use: applying ATC\/DDD methodology to real-world data","volume":"9","author":"Hollingworth","year":"2021","journal-title":"Pharmacy"},{"key":"10.1016\/j.schres.2026.01.003_bb0095","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/BF00789044","article-title":"A comparison of clinical and research DSM-III-R diagnoses of schizophrenia in a Finnish national birth cohort. Clinical and research diagnoses of schizophrenia","volume":"32","author":"Isohanni","year":"1997","journal-title":"Soc. Psychiatry Psychiatr. Epidemiol."},{"key":"10.1016\/j.schres.2026.01.003_bb0100","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.schres.2024.01.033","article-title":"Characteristics of incident substance-induced psychosis compared to first-episode psychotic disorders: a nationwide register-linkage study from Sweden","volume":"264","author":"Jeyapalan","year":"2024","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2026.01.003_bb0105","doi-asserted-by":"crossref","DOI":"10.2174\/0118743501297735240510161825","article-title":"Substances led to psychosis: a systematic review","volume":"17","author":"Karimi","year":"2024","journal-title":"Open Psychol. J."},{"key":"10.1016\/j.schres.2026.01.003_bb0110","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-013881","article-title":"Pharmacological guidelines for schizophrenia: a systematic review and comparison of recommendations for the first episode","volume":"7","author":"Keating","year":"2017","journal-title":"BMJ Open"},{"issue":"9","key":"10.1016\/j.schres.2026.01.003_bb8020","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1176\/appi.ajp.2019.18101217","article-title":"Prediction of onset of substance-induced psychotic disorder and its progression to schizophrenia in a Swedish national sample","volume":"176","author":"Kendler","year":"2019","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2026.01.003_bb0125","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1192\/bjp.bp.117.201475","article-title":"Remission and recovery from first-episode psychosis in adults: systematic review and meta-analysis of long-term outcome studies","volume":"211","author":"Lally","year":"2017","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.schres.2026.01.003_bb0130","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/S2215-0366(22)00304-2","article-title":"The response of subgroups of patients with schizophrenia to different antipsychotic drugs: a systematic review and meta-analysis","volume":"9","author":"Leucht","year":"2022","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.schres.2026.01.003_bb0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0267808","article-title":"Long-acting injectable antipsychotics for early psychosis: a comprehensive systematic review","volume":"17","author":"Lian","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.schres.2026.01.003_bb0145","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1192\/bjp.bp.116.182683","article-title":"Should psychiatrists be more cautious about the long-term prophylactic use of antipsychotics?","volume":"209","author":"Murray","year":"2016","journal-title":"Br. J. Psychiatry"},{"issue":"3","key":"10.1016\/j.schres.2026.01.003_bb8025","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/schbul\/sbz102","article-title":"Transition of substance-induced, brief, and atypical psychoses to schizophrenia: a systematic review and meta-analysis","volume":"46","author":"Murrie","year":"2020","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2026.01.003_bb0150","article-title":"Real-world effectiveness of antipsychotic medication in relapse prevention after cannabis-induced psychosis","volume":"1\u20137","author":"Mustonen","year":"2025","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.schres.2026.01.003_bb0155","first-page":"339","article-title":"Third-generation antipsychotics and lurasidone in the treatment of substance-induced psychoses: a narrative review","volume":"12","author":"Ricci","year":"2024","journal-title":"Healthcare (Switzerland)"},{"issue":"11","key":"10.1016\/j.schres.2026.01.003_bb8030","doi-asserted-by":"crossref","first-page":"5246","DOI":"10.1017\/S003329172200229X","article-title":"Annual incidence of substance-induced psychoses in Scandinavia from 2000 to 2016","volume":"53","author":"Rognli","year":"2023","journal-title":"Psychol. Med."},{"key":"10.1016\/j.schres.2026.01.003_bb0160","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1093\/schbul\/sbab063","article-title":"Long-term continuity of antipsychotic treatment for schizophrenia: a nationwide study","volume":"47","author":"Rubio","year":"2021","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2026.01.003_bb0165","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.neubiorev.2020.07.007","article-title":"Cannabis, nicotine and the negative symptoms of schizophrenia: systematic review and meta-analysis of observational studies","volume":"116","author":"Sabe","year":"2020","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.schres.2026.01.003_bb0170","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/j.1521-0391.2014.12126.x","article-title":"Ziprasidone versus clozapine in the treatment of dually diagnosed (DD) patients with schizophrenia and cannabis use disorders: a randomized study","volume":"23","author":"Schnell","year":"2014","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.schres.2026.01.003_bb0175","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.psychres.2014.11.002","article-title":"A systematic review of factors influencing adherence to antipsychotic medication in schizophrenia-spectrum disorders","volume":"225","author":"Sendt","year":"2015","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.schres.2026.01.003_bb0180","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.psychres.2011.05.001","article-title":"Olanzapine vs. risperidone in patients with first-episode schizophrenia and a lifetime history of cannabis use disorders: 16-week clinical and substance use outcomes","volume":"188","author":"Sevy","year":"2011","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.schres.2026.01.003_bb0185","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.schres.2019.09.013","article-title":"Antipsychotic treatment in the maintenance phase of schizophrenia: an updated systematic review of the guidelines and algorithms","volume":"215","author":"Shimomura","year":"2020","journal-title":"Schizophr. Res."},{"issue":"3","key":"10.1016\/j.schres.2026.01.003_bb8035","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1192\/bjp.2021.61","article-title":"Rates of treatment-resistant schizophrenia from first-episode cohorts: systematic review and meta-analysis","volume":"220","author":"Siskind","year":"2022","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.schres.2026.01.003_bb0190","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1176\/appi.ajp.21121189","article-title":"Effectiveness of antipsychotic use for reducing risk of work disability: results from a within-subject analysis of a Swedish National Cohort of 21,551 patients with first-episode nonaffective psychosis","volume":"179","author":"Solmi","year":"2022","journal-title":"Am. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.schres.2026.01.003_bb8040","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1176\/appi.ajp.2017.17020223","article-title":"Rates and predictors of conversion to schizophrenia or bipolar disorder following substance-induced psychosis","volume":"175","author":"Starzer","year":"2018","journal-title":"Am. J. Psychiatry"},{"issue":"5","key":"10.1016\/j.schres.2026.01.003_bb8045","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/08039488.2020.1854853","article-title":"Antipsychotic use among persons with schizophrenia in Sweden and Finland, trends and differences","volume":"75","author":"Taipale","year":"2021","journal-title":"Nord. J. Psychiatry"},{"key":"10.1016\/j.schres.2026.01.003_bb0195","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S2215-0366(22)00015-3","article-title":"Real-world effectiveness of antipsychotic doses for relapse prevention in patients with first-episode schizophrenia in Finland: a nationwide, register-based cohort study","volume":"9","author":"Taipale","year":"2022","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.schres.2026.01.003_bb0200","doi-asserted-by":"crossref","DOI":"10.1186\/s12911-015-0140-z","article-title":"From prescription drug purchases to drug use periods \u2013 a second generation method (PRE2DUP)","volume":"15","author":"Tanskanen","year":"2015","journal-title":"BMC Med. Inform. Decis. Mak."},{"key":"10.1016\/j.schres.2026.01.003_bb0210","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1176\/appi.ajp.2018.17091001","article-title":"20-year nationwide follow-up study on discontinuation of antipsychotic treatment in first-episode schizophrenia","volume":"175","author":"Tiihonen","year":"2018","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2026.01.003_bb0220","article-title":"Brain structure alterations in poly-drug use: reduced cortical thickness and white matter impairments in regions associated with affective, cognitive, and motor functions","volume":"10","author":"Unterrainer","year":"2019","journal-title":"Front. Psych."},{"key":"10.1016\/j.schres.2026.01.003_bb0225","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.schres.2013.07.004","article-title":"Preventing a first episode of psychosis: Meta-analysis of randomized controlled prevention trials of 12 month and longer-term follow-ups","volume":"149","author":"Van Der Gaag","year":"2013","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2026.01.003_bb0240","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12888-017-1425-9","article-title":"Experiences of antipsychotic use in patients with early psychosis: a two-year follow-up study","volume":"17","author":"Yeisen","year":"2017","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.schres.2026.01.003_bb0245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41537-022-00276-2","article-title":"Antipsychotic-induced weight gain and metabolic effects show diurnal dependence and are reversible with time restricted feeding","volume":"8","author":"Zapata","year":"2022","journal-title":"Schizophrenia"}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996426000034?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996426000034?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T11:24:31Z","timestamp":1774869871000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996426000034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":47,"alternative-id":["S0920996426000034"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2026.01.003","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antipsychotic use and associating factors among persons with substance-induced psychosis and first-episode psychotic disorder- A nationwide register-linkage study","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2026.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}